查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600252

合成生物学市场：按工具、技术和最终用途划分 - 全球预测 2025-2030

Synthetic Biology Market by Tools (DNA Tools, General Tools, Mathematical Modelling & Computer-aided Design Tools), Technology (Bioinformatics, Cell Sequencing, Cell Synthesis & Assembly), End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年合成生物学市值为138.8亿美元，预计2024年将达到166.1亿美元，复合年增长率为21.33%，到2030年将达到537.6亿美元。

合成生物学结合了生物学、工程学、电脑科学和化学的元素，设计和建构新的生物组件、设备和系统，或改进现有的生物组件、设备和系统以达到有用的目的。对合成生物学的需求正在彻底改变各个领域，包括透过培育抗病作物来进行农业、透过用于药物生产和个人化医疗的人工生物体进行医疗保健，以及透过开发降解污染物的生物体来进行环境管理。其应用范围从生质燃料为能源）到工业领域（生产化学品、材料和酵素）。最终用途范围延伸至学术界、研究组织和许多寻求创新解决方案应对世界挑战的商业产业。

主要市场统计
基准年[2023] 138.8亿美元
预测年份 [2024] 166.1亿美元
预测年份 [2030] 537.6亿美元
复合年增长率（%） 21.33%

合成生物学市场的主要成长动力包括基因工程技术的进步、生物技术研究投资的增加以及对永续和环境友善解决方案不断增长的需求。人们对精准医疗和个人化治疗的兴趣日益浓厚，进一步推动了市场的进步。目前的商机主要集中在学术机构和生物技术公司之间的合作、扩展 CRISPR 技术以及整合人工智慧以改善生物设计流程。为了利用这些优势，相关人员应优先考虑对研发的投资，建立策略伙伴关係，并与政策制定者合作以推动监管环境。然而，伦理问题、潜在的生物安全风险以及高昂的研发成本等挑战构成了主要障碍。生物系统的复杂性可能导致不可预测的结果，这也阻碍了市场的成长。

正在考虑尖端创新，包括基因组合成、即时监测生物感测器的开发以及合成生物学在太空探勘中的作用。投资可扩展的合成生物製造技术可以显着提高经济效益。合成生物学市场的特点是动态成长、不断创新和紧密的跨学科合作。为了取得成功，公司应该保持适应能力，与监管机构进行持续对话，并专注于满足特定社会需求的突破，同时确保道德标准得到遵守。

市场动态：揭示快速发展的合成生物市场的关键市场洞察

供需的动态交互作用正在改变合成生物学市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 增加新药和疫苗开发的使用
    • 扩展基于合成生物学的照护现场诊断设备
    • 各种工业应用对合成生物学的需求不断成长
  • 市场限制因素
    • 与使用合成生物学技术相关的风险
  • 市场机会
    • 基因编辑与次世代定序仪的技术进步
    • 增加研发经费和投资以扩大合成生物学应用
  • 市场挑战
    • 使用合成生物学对生物部件进行模组化和标准化的限制

波特的五力：驾驭合成生物市场的策略工具

波特的五力框架是了解合成生物学市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解合成生物市场的外部影响

外部宏观环境因素在塑造合成生物市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解合成生物学市场的竞争格局

合成生物学市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵合成生物学市场供应商的绩效评估

FPNV定位矩阵是评估合成生物市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了合成生物学市场的成功之路

对于想要加强在全球市场的影响力的公司来说，合成生物学市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 增加在新药和疫苗开发的使用
      • 扩展基于合成生物学的照护现场诊断设备
      • 各种工业应用对合成生物学的需求不断增加
    • 抑制因素
      • 与使用合成生物学技术相关的风险
    • 机会
      • 基因编辑与次世代定序的技术进步
      • 增加研发经费和投资以扩大合成生物学应用
    • 任务
      • 合成生物学在生物成分模组化和标准化的限制
  • 市场区隔分析
    • 工具：探索推动合成生物学创新的基本工具
    • 最终用途：合成生物学在改变最终用途产业的崛起
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 合成生物市场（按工具）

  • 脱氧核糖核酸工具
  • 常用工具
  • 数学建模和电脑辅助设计工具
  • 蛋白质工具
  • RNA工具

第七章合成生物市场：依技术分类

  • 生物资讯学
  • 细胞序列分析
  • 细胞合成与组装
  • 复製
  • 微流体
  • 奈米科技
  • 体学技术
  • 定点突变

第八章合成生物市场：依最终用途

  • 农业
  • 化妆品/个人护理
  • 能源和自然资源
  • 环境
    • 生物修復
    • 生物感
  • 饮食
  • 医疗保健/製药
    • 人工组织和组织再生
    • 药物发现与治疗
  • 纸张/纤维

第九章美洲合成生物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区合成生物市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲合成生物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Asimov 和 iGEM 合作培养合成生物学领域的未来领导者
    • NREL 与领先机构合作，透过合成生物学加速生质燃料创新。
    • Moderna 透过收购日本基因组公司 Orichiro 扩大 mRNA 能力
  • 战略分析和建议

公司名单

  • Agilent Technologies, Inc.
  • Amyris, Inc.
  • Arzeda
  • Batavia Biosciences BV
  • Beam Therapeutics
  • Beckman Coulter, Inc.
  • BGI Genomics Co., Ltd.
  • Codexis, Inc.
  • Conagen, Inc.
  • Creative Enzymes
  • DNA TwoPointO Inc.
  • Editas Medicine, Inc.
  • Eurofins Scientific
  • GenScript Biotech Corporation
  • Ginkgo Bioworks, Inc.
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Merck KGaA
  • New England Biolabs GmbH
  • Novozymes A/S
  • Precigen, Inc.
  • QIAGEN NV
  • Sangamo Therapeutics
  • Scarab Genomics, LLC
  • Synlogic
  • Synthego Corporation
  • TeselaGen Service
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
Product Code: MRR-B9334AD6BE33

The Synthetic Biology Market was valued at USD 13.88 billion in 2023, expected to reach USD 16.61 billion in 2024, and is projected to grow at a CAGR of 21.33%, to USD 53.76 billion by 2030.

Synthetic biology is an interdisciplinary field that combines elements of biology, engineering, computer science, and chemistry to design and construct new biological parts, devices, and systems or to modify existing ones for useful purposes. The necessity of synthetic biology lies in its potential to revolutionize various sectors, such as agriculture, by creating disease-resistant crops; healthcare, through engineered organisms for drug production and personalized medicine; and environmental management, by developing organisms that can break down pollutants. Its application extends to biofuel production, where engineered microbes efficiently convert biomass into energy, and the industrial sector for producing chemicals, materials, and enzymes. The end-use scope extends to academia, research institutions, and a host of commercial industries seeking innovative solutions to global challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 13.88 billion
Estimated Year [2024] USD 16.61 billion
Forecast Year [2030] USD 53.76 billion
CAGR (%) 21.33%

Key growth drivers for the synthetic biology market include advancements in genetic engineering technologies, increased investment in biotech research, and a rising demand for sustainable and eco-friendly solutions. The burgeoning interest in precision medicine and tailored therapies further propels market advancements. Present opportunities focus on collaborations between academic institutions and biotech firms, expansion of CRISPR technology, and the integration of artificial intelligence for improved bio-design processes. To capitalize on these, stakeholders should prioritize investments in R&D, forge strategic partnerships, and engage with policy-makers to foster conducive regulatory landscapes. However, challenges such as ethical concerns, potential biosecurity risks, and high R&D costs pose significant barriers. Market growth is also hampered by the complexities of biological systems which can result in unpredictable outcomes.

Cutting-edge innovations are being contemplated in genome synthesis, the development of biosensors for real-time monitoring, and synthetic biology's role in space exploration. Investing in scalable synthetic bio-manufacturing technologies could significantly boost economic viability. The synthetic biology market is characterized by dynamic growth, continuous innovation, and intense collaboration across disciplines. To thrive, businesses should remain adaptable, engage in ongoing dialogue with regulatory bodies, and focus on breakthroughs that address specific societal needs while ensuring ethical standards are upheld.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Synthetic Biology Market

The Synthetic Biology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing use for novel drug and vaccines development
    • Expansion of synthetic biology based point-of-care diagnostics devices
    • Accelerating demand for synthetic biology in various industrial applications
  • Market Restraints
    • Risks associated with the use of synthetic biology technology
  • Market Opportunities
    • Technological advancements in gene editing and next generation sequencing
    • Rising R&D funding and investments for expansion of synthetic biology applications
  • Market Challenges
    • Constraints of synthetic biology in modularization and standardization of biological parts

Porter's Five Forces: A Strategic Tool for Navigating the Synthetic Biology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Synthetic Biology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Synthetic Biology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Synthetic Biology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Synthetic Biology Market

A detailed market share analysis in the Synthetic Biology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Synthetic Biology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Synthetic Biology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Synthetic Biology Market

A strategic analysis of the Synthetic Biology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Synthetic Biology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Amyris, Inc., Arzeda, Batavia Biosciences B.V., Beam Therapeutics, Beckman Coulter, Inc., BGI Genomics Co., Ltd., Codexis, Inc., Conagen, Inc., Creative Enzymes, DNA TwoPointO Inc., Editas Medicine, Inc., Eurofins Scientific, GenScript Biotech Corporation, Ginkgo Bioworks, Inc., Illumina, Inc., Integrated DNA Technologies, Inc., Merck KGaA, New England Biolabs GmbH, Novozymes A/S, Precigen, Inc., QIAGEN N.V., Sangamo Therapeutics, Scarab Genomics, LLC, Synlogic, Synthego Corporation, TeselaGen Service, Thermo Fisher Scientific Inc., and Twist Bioscience Corporation.

Market Segmentation & Coverage

This research report categorizes the Synthetic Biology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Tools, market is studied across DNA Tools, General Tools, Mathematical Modelling & Computer-aided Design Tools, Protein Tools, and RNA Tools.
  • Based on Technology, market is studied across Bioinformatics, Cell Sequencing, Cell Synthesis & Assembly, Cloning, Microfluidics, Nanotechnology, Omics Technologies, and Site-directed Mutagenesis.
  • Based on End-Use, market is studied across Agriculture, Cosmetics & Personal Care, Energy & Natural Resources, Environment, Food & Beverage, Healthcare & Pharmaceuticals, and Paper & Textile. The Environment is further studied across Bioremediation and Biosensing. The Healthcare & Pharmaceuticals is further studied across Artificial Tissue & Tissue Regeneration and Drug Discovery & Therapeutics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use for novel drug and vaccines development
      • 5.1.1.2. Expansion of synthetic biology based point-of-care diagnostics devices
      • 5.1.1.3. Accelerating demand for synthetic biology in various industrial applications
    • 5.1.2. Restraints
      • 5.1.2.1. Risks associated with the use of synthetic biology technology
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in gene editing and next generation sequencing
      • 5.1.3.2. Rising R&D funding and investments for expansion of synthetic biology applications
    • 5.1.4. Challenges
      • 5.1.4.1. Constraints of synthetic biology in modularization and standardization of biological parts
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Tools: Exploring essential tools for powering innovations in synthetic biology
    • 5.2.2. End-Use: Rise of synthetic biology in transforming end-use industries
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Synthetic Biology Market, by Tools

  • 6.1. Introduction
  • 6.2. DNA Tools
  • 6.3. General Tools
  • 6.4. Mathematical Modelling & Computer-aided Design Tools
  • 6.5. Protein Tools
  • 6.6. RNA Tools

7. Synthetic Biology Market, by Technology

  • 7.1. Introduction
  • 7.2. Bioinformatics
  • 7.3. Cell Sequencing
  • 7.4. Cell Synthesis & Assembly
  • 7.5. Cloning
  • 7.6. Microfluidics
  • 7.7. Nanotechnology
  • 7.8. Omics Technologies
  • 7.9. Site-directed Mutagenesis

8. Synthetic Biology Market, by End-Use

  • 8.1. Introduction
  • 8.2. Agriculture
  • 8.3. Cosmetics & Personal Care
  • 8.4. Energy & Natural Resources
  • 8.5. Environment
    • 8.5.1. Bioremediation
    • 8.5.2. Biosensing
  • 8.6. Food & Beverage
  • 8.7. Healthcare & Pharmaceuticals
    • 8.7.1. Artificial Tissue & Tissue Regeneration
    • 8.7.2. Drug Discovery & Therapeutics
  • 8.8. Paper & Textile

9. Americas Synthetic Biology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Synthetic Biology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Synthetic Biology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Asimov and iGEM Collaborate to Nurture Future Leaders in Synthetic Biology
    • 12.3.2. NREL Partners with Leading Institutions to Accelerate Biofuel Innovations through Synthetic Biology
    • 12.3.3. Moderna Expands mRNA Capabilities with Acquisition of Japanese Genomics Firm Oriciro
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Amyris, Inc.
  • 3. Arzeda
  • 4. Batavia Biosciences B.V.
  • 5. Beam Therapeutics
  • 6. Beckman Coulter, Inc.
  • 7. BGI Genomics Co., Ltd.
  • 8. Codexis, Inc.
  • 9. Conagen, Inc.
  • 10. Creative Enzymes
  • 11. DNA TwoPointO Inc.
  • 12. Editas Medicine, Inc.
  • 13. Eurofins Scientific
  • 14. GenScript Biotech Corporation
  • 15. Ginkgo Bioworks, Inc.
  • 16. Illumina, Inc.
  • 17. Integrated DNA Technologies, Inc.
  • 18. Merck KGaA
  • 19. New England Biolabs GmbH
  • 20. Novozymes A/S
  • 21. Precigen, Inc.
  • 22. QIAGEN N.V.
  • 23. Sangamo Therapeutics
  • 24. Scarab Genomics, LLC
  • 25. Synlogic
  • 26. Synthego Corporation
  • 27. TeselaGen Service
  • 28. Thermo Fisher Scientific Inc.
  • 29. Twist Bioscience Corporation

LIST OF FIGURES

  • FIGURE 1. SYNTHETIC BIOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. SYNTHETIC BIOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SYNTHETIC BIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SYNTHETIC BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SYNTHETIC BIOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SYNTHETIC BIOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY DNA TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY GENERAL TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY MATHEMATICAL MODELLING & COMPUTER-AIDED DESIGN TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY RNA TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY CELL SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY CELL SYNTHESIS & ASSEMBLY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY CLONING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY NANOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY OMICS TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY SITE-DIRECTED MUTAGENESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY COSMETICS & PERSONAL CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY ENERGY & NATURAL RESOURCES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY BIOREMEDIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY BIOSENSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY ARTIFICIAL TISSUE & TISSUE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY DRUG DISCOVERY & THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY PAPER & TEXTILE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 89. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 94. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 99. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 100. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 104. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 105. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 108. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 109. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 110. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 113. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 114. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 115. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 118. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 119. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 120. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 123. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 124. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 125. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 127. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 128. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 129. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 130. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 132. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 133. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 140. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 141. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 144. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 145. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 146. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 148. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 149. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 150. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 151. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 154. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 155. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 156. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 158. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 159. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 160. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 161. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 163. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 164. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 165. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 166. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 168. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 169. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 170. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 171. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 174. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 175. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 176. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 178. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 179. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 180. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 181. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 183. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 184. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 185. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 186. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 188. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 189. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 190. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 191. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 193. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 194. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 195. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 196. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 198. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 199. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 200. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 201. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 202. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 203. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 204. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 205. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 206. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 208. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 209. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 213. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 214. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 215. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 216. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 217. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 218. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 219. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 220. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 221. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 223. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 224. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 225. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 226. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 228. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 229. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 230. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 231. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 233. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 234. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 242. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
  • TABLE 244. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 245. SYNTHETIC BIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 246. SYNTHETIC BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023